Speakers
Co-Chairs
Heidi Gertner
Partner
Hogan Lovells LLP
Liping Wu
MD, PhD, RAC, Global Regulatory Affairs Manager
Kenvue
Distinguished Faculty
Ann Begley
Partner
Wiley Rein LLP
Dan Brum
PharmD, MBA, BCPS, Chief of Project Management, Office of Nonprescription Drugs
Food and Drug Administration (FDA)
Cathy Burgess
Partner
Alston & Bird LLP
Ludjane Carvalho
Director Regulatory Affairs
Colgate-Palmolive
Kellie Combs
Partner
Ropes & Gray
Daniel R. Dwyer
Partner
Kleinfeld Kaplan & Becker LLP
Kyle Y. Faget
Partner
Foley & Lardner LLP
Shoshana Golden
Attorney
ArentFox Schiff LLP
Monica C. Groat
Counsel
Latham & Watkins LLP
David Grob
Vice President, Regulatory Affairs
Pocket Naloxone Company
Todd Halpern
Assistant General Counsel
Haleon
Todd Harrison
Partner
Venable LLP
Bethany J. Hills
Vice Chair FDA Regulatory Practice
DLA Piper LLP (US)
David Horowitz
Partner
Hogan Lovells US LLP
John F. Johnson III
Senior Counsel
Shook, Hardy & Bacon L.L.P
Kristen Klesh
Partner
Loeb & Loeb LLP
Deborah Livornese
Partner
Hyman, Phelps & McNamara P.C.
Stephen McConnell
Partner
Reed Smith LLP
Diane McEnroe
Partner
Sidley Austin LLP
Meghan G. Walters Price
Director and Assistant General Counsel
The Procter & Gamble Company
James Prochnow
Partner
Greenberg Traurig LLP
Nikki Reeves
Partner
King & Spalding LLP
Amy Repolgle
Director, Rx-to-OTC Switch
Bayer
Paul D. Rubin
Partner
Debevoise & Plimpton LLP
Jennifer Santos
Attorney
National Advertising Division (NAD)
May Smith
Marketing Director, Rx to OTC Switch
Haleon
Andrew Soukup
Partner
Covington & Burling LLP
Frederick A. Stearns
Partner
Keller and Heckman LLP
